Outcomes in Patients with Intact and Resected #BrainMetastasis Treated with 5-Fraction Stereotactic Radiosurgery Peter Fecci John H. Sampson, MD Scott Floyd ncbi.nlm.nih.gov/pmc/articles/P…

Duke Center for Brain and Spine Metastasis Peter Fecci

#Wasserman Wednesday . Phenomenal @uclaneurosurgery Grand Rounds with Dr. Peter Fecci from @dukeneurosurgery and Dr. Michael Ivan from Tim Umbach Miller Medicine, @ucsfneurosurgery #alumni! . . #UCLAHealth #neurosurgery

Looking forward to Friday morning wisdom for young neurosurgeons from Peter Fecci at #AANS2023

Saturday at #AANS2023, hear from our director, Peter Fecci on #BrainMetastases. Duke Neurosurgery

Amazing session discussing pearls for being a productive Neurosurgeon-Scientist Grateful for the expertise from the panel including Peter Fecci @isaacyangmd John H. Shin MD, MBA Jennifer Strahle, MD James Rutka Daniel Sciubba Dr. Ricardo J Komotar Laura Stone McGuire, MD @nitinagarwalmd Aladine Elsamadicy, MD #AANS2023

Excellent talks by Peter Fecci, Jennifer Strahle, MD, and many others at the #AANS2023 Guide to Successful Research session yesterday. Such valuable information that isn’t always covered for medical students. Some key takeaways:

Poster from Duke University School of Medicine student, member of Peter Fecci's lab and all-round superstar Aden Mendoza, MD, MS : "Association of Patient Race/Ethnicity with LITT Referral Patterns at a Single Center." #AANS2023 @FLNSUS

A Duke study published today in Nature Cancer disrupts a long-held paradigm for tumor resistance to #Immunotherapy. Emily Lerner Peter Fecci Preston Robert Tisch Brain Tumor Center @ Duke Duke Cancer Duke University School of Medicine Duke Research & Innovation Duke Department of Medicine neurosurgery.duke.edu/news/new-study…

Life changing, dogma-smashing, textbook-changing, and awesome paper by Emily Lerner and Peter Fecci and the rest of the wonderful Fecci lab Selena Lorrey, PhD Daniel Wilkinson and others who contributed to this amazing story nature.com/articles/s4301…

⭐️NEW ARTICLE Nature Cancer “CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis” by Emily Lerner Peter Fecci & Co. Don’t miss it👇 nature.com/articles/s4301… rdcu.be/diyEb

📣 Next week's episode features Dr. Peter Fecci from @DukeNeurosurg! His research focuses on brain tumor immunology and #immunotherapy. 🧠 Check out his lab's recent Nature Cancer paper on targeting MHC-I-negative tumor cells: bit.ly/3ZKTfWk

Ep. 64: "Brain Tumor Immunotherapy" Featuring Dr. Peter Fecci - The Immunology Podcast immunologypodcast.com/ep-64-brain-tu…

Intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses biorxiv.org/cgi/content/sh… #bioRxiv

Monteris Medical Announces Extended Aetna® Coverage of its NeuroBlate® System Laser Interstitial Thermal Therapy for Brain Tumor Patients - Monteris monteris.com/press-releases…

NCI SPORE meeting at the beautiful new TMC3 facility at MD Anderson

Congratulations to my latest graduate student to graduate: Alexandra Hoyt Miggelbrink, MD, PhD

Rep. Foushee Introduces Resolution Designating June as Brain and Spine Metastasis Awareness Month - Valerie Foushee. This as a result of the hard work of our outstanding DCBSM team! foushee.house.gov/posts/rep-fous…

Metastatic cancer treatments advance, offer new hope to patients - ABC11 Raleigh-Durham abc11.com/post/metastati…

"Fostering collaborations with local healthcare providers and providing info through trusted and respected channels...can help bridge the gap in healthcare disparities and improve outcomes in underserved regions," expresses CRI Lloyd J. Old STAR Dr. Iliev: bit.ly/3DeNDMM